241 related articles for article (PubMed ID: 25703856)
1. Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: a qualitative insight into the perspectives of surgeons and medical oncologists.
van Erning FN; Janssen-Heijnen ML; Creemers GJ; Pruijt HF; Maas HA; Lemmens VE
J Geriatr Oncol; 2015 May; 6(3):219-24. PubMed ID: 25703856
[TBL] [Abstract][Full Text] [Related]
2. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
[TBL] [Abstract][Full Text] [Related]
4. The Course of Neuropathic Symptoms in Relation to Adjuvant Chemotherapy Among Elderly Patients With Stage III Colon Cancer: A Longitudinal Study.
van Erning FN; Janssen-Heijnen MLG; Wegdam JA; Slooter GD; Wijsman JH; Vreugenhil A; Beijers TAJM; van de Poll-Franse LV; Lemmens VEPP
Clin Colorectal Cancer; 2017 Sep; 16(3):195-203. PubMed ID: 27756521
[TBL] [Abstract][Full Text] [Related]
5. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
6. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer.
Kirkpatrick HM; Aitelli CL; Qin H; Becerra C; Lichliter WE; McCollum AD
Clin Colorectal Cancer; 2010 Jul; 9(3):150-6. PubMed ID: 20643619
[TBL] [Abstract][Full Text] [Related]
7. Differences in the outcomes of adjuvant chemotherapy for colon cancer prescribed by physicians in different disciplines: a population-based study in Taiwan.
Hsieh CI; Kuo RN; Liang CC; Tsai HY; Chung KP
BMJ Open; 2018 Dec; 8(12):e021341. PubMed ID: 30567819
[TBL] [Abstract][Full Text] [Related]
8. Patient age and cancer treatment decisions. Patient and physician views.
Kutner JS; Vu KO; Prindiville SA; Byers TE
Cancer Pract; 2000; 8(3):114-9. PubMed ID: 11898135
[TBL] [Abstract][Full Text] [Related]
9. Decision-making under clinical uncertainty: An in-depth examination of provider perspectives on adjuvant chemotherapy for stage II colon cancer.
Shelton RC; Brotzman LE; Crookes DM; Robles P; Neugut AI
Patient Educ Couns; 2019 Feb; 102(2):284-290. PubMed ID: 30262401
[TBL] [Abstract][Full Text] [Related]
10. Medical Oncologists' Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer.
Yu IS; Pereira AAL; Lee M; Korphaisarn K; Marshall J; Segelov E; O'Callaghan C; Lim HJ; Kopetz S; Loree JM
Oncologist; 2020 Mar; 25(3):229-234. PubMed ID: 32162828
[TBL] [Abstract][Full Text] [Related]
11. Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients.
Becerra AZ; Aquina CT; Mohile SG; Tejani MA; Schymura MJ; Boscoe FP; Xu Z; Justiniano CF; Boodry CI; Swanger AA; Noyes K; Monson JR; Fleming FJ
Ann Surg Oncol; 2017 Jun; 24(6):1610-1617. PubMed ID: 27738848
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.
van Gils CW; Koopman M; Mol L; Redekop WK; Uyl-de Groot CA; Punt CJ
Acta Oncol; 2012 Jan; 51(1):57-64. PubMed ID: 22122695
[TBL] [Abstract][Full Text] [Related]
13. How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists.
Moth EB; Kiely BE; Naganathan V; Martin A; Blinman P
Support Care Cancer; 2018 Feb; 26(2):451-460. PubMed ID: 28776149
[TBL] [Abstract][Full Text] [Related]
14. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.
van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW;
Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338
[TBL] [Abstract][Full Text] [Related]
15. Predictors of referral for adjuvant therapy for colorectal cancer.
Ong S; Watters JM; Grunfeld E; O'Rourke K
Can J Surg; 2005 Jun; 48(3):225-9. PubMed ID: 16013627
[TBL] [Abstract][Full Text] [Related]
16. Current status on microsatellite instability, prognosis and adjuvant therapy in colon cancer: A nationwide survey of medical oncologists, colorectal surgeons and gastrointestinal pathologists.
Toh JWT; Mahajan H; Chapuis P; Spring K
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1297. PubMed ID: 33030308
[TBL] [Abstract][Full Text] [Related]
17. The influences of age and co-morbidities on treatment decisions for patients with HER2-positive early breast cancer.
Ring A
Crit Rev Oncol Hematol; 2010 Nov; 76(2):127-32. PubMed ID: 20097087
[TBL] [Abstract][Full Text] [Related]
18. Why adjuvant chemotherapy for stage III colon cancer was not given: Reasons for non-recommendation by clinicians or patient refusal.
Gilbar P; Lee A; Pokharel K
J Oncol Pharm Pract; 2017 Mar; 23(2):128-134. PubMed ID: 26692241
[TBL] [Abstract][Full Text] [Related]
19. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer.
Luo R; Giordano SH; Freeman JL; Zhang D; Goodwin JS
Oncologist; 2006 Oct; 11(9):1025-33. PubMed ID: 17030645
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.
Winget M; Hossain S; Yasui Y; Scarfe A
Cancer; 2010 Oct; 116(20):4849-56. PubMed ID: 20578180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
